Publication | Closed Access
Phase I Study of Pegylated Liposomal Doxorubicin in Combination With Ifosfamide in Pretreated Ovarian Cancer Patients
10
Citations
21
References
2006
Year
This study regimen presents an acceptable tolerance. The preliminary assessment of efficacy merits confirmation in a phase II study.
| Year | Citations | |
|---|---|---|
Page 1
Page 1